Safety and efficacy of monthly high-dose vitamin D₃ supplementation in children and adolescents with sickle cell disease.

All groups succeeded in restoring sufficient vitamin D status except the deficient SCD group with a median level of 25.5 (20.5–34) at 6-month post-intervention; however, there was a highly significant improvement from baseline levels ( P < 0.001).

also in 132,142 other papers